Cargando…

Alterations of the gut microbiota in patients with postherpetic neuralgia

Postherpetic neuralgia (PHN) is a prevalent, intricate, and intractable form of neuropathic pain. The available evidence indicates that alterations in the gut microbiota are significant environmental determinants in the development of chronic neuropathic pain. Nevertheless, the correlation between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Bo, Cao, Xueqin, Zhang, Caixia, Zhang, Wencui, Yu, Shangchen, Zhang, Mi, Zhang, Xianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558420/
https://www.ncbi.nlm.nih.gov/pubmed/37803181
http://dx.doi.org/10.1186/s13568-023-01614-y
_version_ 1785117271232872448
author Jiao, Bo
Cao, Xueqin
Zhang, Caixia
Zhang, Wencui
Yu, Shangchen
Zhang, Mi
Zhang, Xianwei
author_facet Jiao, Bo
Cao, Xueqin
Zhang, Caixia
Zhang, Wencui
Yu, Shangchen
Zhang, Mi
Zhang, Xianwei
author_sort Jiao, Bo
collection PubMed
description Postherpetic neuralgia (PHN) is a prevalent, intricate, and intractable form of neuropathic pain. The available evidence indicates that alterations in the gut microbiota are significant environmental determinants in the development of chronic neuropathic pain. Nevertheless, the correlation between the gut microbiota and PHN remains elusive. A cross-sectional study was performed on a cohort of 27 patients diagnosed with PHN and 27 matched healthy controls. Fecal samples were collected and subjected to microbiota analysis using 16S ribosomal RNA gene sequencing. Comparable levels of bacterial richness and diversity were observed in the gut microbiota of PHN patients and healthy controls. A significant difference was observed in 37 genera between the two groups. Furthermore, the LEfSe method revealed that the abundance levels of Escherichia-Shigella, Streptococcus, Ligilactobacillus, and Clostridia_UCG-014_unclassified were elevated in PHN patients, while Eubacterium_hallii_group, Butyricicoccus, Tyzzerella, Dorea, Parasutterella, Romboutsia, Megamonas, and Agathobacter genera were reduced in comparison to healthy controls. Significantly, the discriminant model utilizing the predominant microbiota exhibited efficacy in distinguishing PHN patients from healthy controls, with an area under the curve value of 0.824. Moreover, Spearman correlation analysis demonstrated noteworthy correlations between various gut microbiota and clinical symptoms, including disease course, anxiety state, sleep quality, heat pain, pain intensity, and itching intensity. Gut microbiota dysbiosis exists in PHN patients, microbiome differences could be used to distinguish PHN patients from normal healthy individuals with high sensitivity and specificity, and altered gut microbiota are related to clinical manifestations, suggesting potentially novel prevention and therapeutic directions of PHN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13568-023-01614-y.
format Online
Article
Text
id pubmed-10558420
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105584202023-10-08 Alterations of the gut microbiota in patients with postherpetic neuralgia Jiao, Bo Cao, Xueqin Zhang, Caixia Zhang, Wencui Yu, Shangchen Zhang, Mi Zhang, Xianwei AMB Express Original Article Postherpetic neuralgia (PHN) is a prevalent, intricate, and intractable form of neuropathic pain. The available evidence indicates that alterations in the gut microbiota are significant environmental determinants in the development of chronic neuropathic pain. Nevertheless, the correlation between the gut microbiota and PHN remains elusive. A cross-sectional study was performed on a cohort of 27 patients diagnosed with PHN and 27 matched healthy controls. Fecal samples were collected and subjected to microbiota analysis using 16S ribosomal RNA gene sequencing. Comparable levels of bacterial richness and diversity were observed in the gut microbiota of PHN patients and healthy controls. A significant difference was observed in 37 genera between the two groups. Furthermore, the LEfSe method revealed that the abundance levels of Escherichia-Shigella, Streptococcus, Ligilactobacillus, and Clostridia_UCG-014_unclassified were elevated in PHN patients, while Eubacterium_hallii_group, Butyricicoccus, Tyzzerella, Dorea, Parasutterella, Romboutsia, Megamonas, and Agathobacter genera were reduced in comparison to healthy controls. Significantly, the discriminant model utilizing the predominant microbiota exhibited efficacy in distinguishing PHN patients from healthy controls, with an area under the curve value of 0.824. Moreover, Spearman correlation analysis demonstrated noteworthy correlations between various gut microbiota and clinical symptoms, including disease course, anxiety state, sleep quality, heat pain, pain intensity, and itching intensity. Gut microbiota dysbiosis exists in PHN patients, microbiome differences could be used to distinguish PHN patients from normal healthy individuals with high sensitivity and specificity, and altered gut microbiota are related to clinical manifestations, suggesting potentially novel prevention and therapeutic directions of PHN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13568-023-01614-y. Springer Berlin Heidelberg 2023-10-06 /pmc/articles/PMC10558420/ /pubmed/37803181 http://dx.doi.org/10.1186/s13568-023-01614-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Jiao, Bo
Cao, Xueqin
Zhang, Caixia
Zhang, Wencui
Yu, Shangchen
Zhang, Mi
Zhang, Xianwei
Alterations of the gut microbiota in patients with postherpetic neuralgia
title Alterations of the gut microbiota in patients with postherpetic neuralgia
title_full Alterations of the gut microbiota in patients with postherpetic neuralgia
title_fullStr Alterations of the gut microbiota in patients with postherpetic neuralgia
title_full_unstemmed Alterations of the gut microbiota in patients with postherpetic neuralgia
title_short Alterations of the gut microbiota in patients with postherpetic neuralgia
title_sort alterations of the gut microbiota in patients with postherpetic neuralgia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558420/
https://www.ncbi.nlm.nih.gov/pubmed/37803181
http://dx.doi.org/10.1186/s13568-023-01614-y
work_keys_str_mv AT jiaobo alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT caoxueqin alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT zhangcaixia alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT zhangwencui alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT yushangchen alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT zhangmi alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia
AT zhangxianwei alterationsofthegutmicrobiotainpatientswithpostherpeticneuralgia